key: cord-0316118-lnli0dqb authors: Chakraborty, Asit Kumar; Saha, Sourajit; Poria, Kousik; Samanta, Tanmoy; Gautam, Sudhanshu; Mukhopadhyay, Jayanta title: An Abundant New Saponin-Polybromophenol Antibiotic (CU1) from Cassia fistula Bark Against Multi-Drug Resistant Bacteria Targeting RNA Polymerase date: 2020-11-05 journal: bioRxiv DOI: 10.1101/2020.11.04.369058 sha: 31eff65bdbff4cc1dd0ab14e6441100e199369f0 doc_id: 316118 cord_uid: lnli0dqb Spread of multidrug-resistant infections is a threat to human race and need for new drug development is great. Bark ethanol extract of Cassia fistula inhibited MDR bacteria isolated from Ganga River water, human and animal. On TLC, a gray colour major band ran fast (CU1; 6.6% of bark and ~30% of crude extract) which quickly purified on HPLC C18 column at 3 min. Chemical assays suggested a triterpene linked to polyphenol known as saponin. CHN Elements analysis (35.9% C; 5.5% H) did not identified nitrogen suggesting a polyphenol or glycoside. VU-Vis spectra gave high peak at below 200nm with a secondary peak at 275nm with minor hinge at 578nm indicating a fused ring with bromo-polyphenol. CU1 Mass (897 Daltons) with fragments of 515, 325, 269, 180 daltons and six halogen substitutions reflected by 82 molecular mass of DBr deviate six larger fragments. FT-IR suggested broad band at 3500-3000 cm−1 for −OH where as two strong peaks at 1552cm−1 for aromatic C=C and 1408cm−1 for phenol. Proton-NMR confirmed polymeric phenol at δ 4.86-4.91 ppm and tetratet at δ3.57-3.618 ppm with phenolic bromo-substituents. Carbon-NMR identified a strong peak at δ=23.7ppm for many C-Br and at 165ppm for a polybenzoid compound. CU1 inhibited the RNA Polymerase of E. coli (IC50=23μg/ml) and M. tuberculosis (IC50=34μg/ml) but not DNA polymerase. Gel shift assays demonstrated that CU1 drug interacted with enzyme and inhibited its binding to open promoter complex. Thus, CU1 phyto-chemical is an alternative safer and low cost drug against MDR-TB as well as other MDR pathogens. Multidrug-resistant pathogenesis has caused a serious threat to society where anyone is susceptible to AMR (antimicrobial resistance) disease if immuno-system is weak. AMR disease is potential threat to life as most common antibiotics (ampicillin, streptomycin, chloramphenicol, ciprofloxacin, cefotaxime, erythromycin etc) did not able to kill bacteria due to presence of mdr genes (bla, amp, cat, acc, aad, str, aph, sul, mcr, erm, cfr, dhfr) in plasmids followed by chromosomal mutations (gyrAB, porB, L4, and rRNA) [1] [2] [3] . MDR genes bla homolouges (TEM, SHV, CTX-M, OXA, VIM, CMY) degrades ampicillin, cefotaxime and meropenem differentially but blaNDM1 enzyme degrade all, whereas CAT enzyme acetylates chloramphenicol only but AAC acetylating enzymes are heterogeneous and inactivate many other drugs. APH enzymes phosphorylate many drugs like streptomycin, azithromycin and amikacin to make inactive drug derivatives. Few dozens mdr genes were isolated and sequenced but million mutated isolates with potential higher drug inactivating capabilities were documented in human infections caused by Salmonella, Pseudomonas, Acinetobacter, Klebsiella, Bacillus and Escherichia species [4] [5] [6] [7] . Importantly, small Rplasmids with 1-3 mdr genes have combined with F'-conjugative plasmid (62.5kb) giving more space to multiple (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) ) mdr genes as well as drug-efflux genes and many recombinases and IS-elements. Such bacteria can donate the mdr genes to other environmental bacteria by conjugation where we found 45% ampicillin resistance bacteria in Ganga River water and Digha sea water but reported clinical isolates were >95% ampicillin resistant [8] . Obviously question arises why such mdr genes creation in bacteria? Scientists predicted that gut bacteria were in symbiosis with human intestinal cells that would be die unless bacteria could supply vitamins. Vitamins as coenzymes (NAD, FAD, Biotin, PALPO, THFA) were component of ten thousands enzymes who made bio-molecules (amino acids, nucleotides, fatty acids and sugars) in our body [9] . Other words, intake of huge oral antibiotics since 1928 killed the gut bacteria and might be a signalling from intestinal cells secreting ILs and CKs (interleukins and cytokines) had helped bacteria to rearranged its plasmids and transposons to create mdr genes so that gut bacteria could live even we used to take multiple doses of oral antibiotics during fever and cough. Due to overwhelming drug void, drug companies are now not investing in new drug discovery against bacteria because it appears the half life for new drug may be few months and then a new mar gene will appear to destroy the drug. For new drug discovery it took two billion dollar and investors are in confusion and fear how they will recover the money from market! In such scenario, G-20 Leaders and WHO have approved a new dimension in drug discovery against multidrug-resistant bacteria from household medicinal plants [10] [11] [12] . Cassia fistula (Fabaceae family) is a deciduous medium sized tree (10-20m hight and 1-2m girth) cultivated in India for medicinal and decorative purposes and is also common throughout the Gangetic vally and sub-Himalayan tracts including other Asian countries like Srilanka, Thiland and Nepal [13] . The different parts (flower, root, bean, ripe fruit pulp, seed and leaves) are used in curing variety of infections and ailments [14] . A 3.5KD small protease inhibitor (Fistulin) was purified from leaves of Cassia fistula having anti-microbial activities [15] . Many chemical constituents have been analyzed from Cassia bean and tree parts [16] [17] [18] [19] [20] [21] . We first reported the role of Cassia fistula bark extract in inhibiting superbugs [12] . In this communication, we have extended such studies purifying the active chemical and identifying its target as RNA polymerase. In bacteria, a single RNA polymerase could transcribe all rRNA, mRNA and tRNAs whereas in eukaryotes three RNA polymerases like Pol I, Pol II and Pol III transcribed those RNAs respectively and also another mitochondrial RNA polymerase was characterized [22] [23] [24] . Bacterial RNA polymerase was inhibited by anti-tuberculosis drug refampicin which was useless in many MDR-TB cases now. Eukaryotic Pol-II was selectively inhibited by α amanitin whereas Pol-I was insensitive to α -amanitin and Pol-III was moderately inhibited at high dose (50µg/ml). RNA polymerases were purified by DEAE-Sephadex column chromatography and were very labile to heat and EDTA. Presently, affinity column was used to quickly purify the enzyme and stored in 50% glycerol [23] . We isolated bark from a medium sized tree (8m) and bark was thick (8mm). We cut 5 mm x 5 mm sized pieces of bark with the help of a knife (zatei) as motorized grinding generated heat to destroy active phyto-chemicals. The extraction was done with ethanol (1:5; w/v). Overnight extraction was good but 2-3 days extraction was found helpful. Ethanol extraction was good but methanol extraction yielded more CU1 than CU3 phytochemicals. Dried bark is good but fresh bark was also not harmful but some water (10%) soluble chemicals were contaminated. Dried extract was active for months in the refrigerator but ethanol extract at room temperature (35 O C) was inactivated quickly. We recovered ~11g solid chemicals from 200g bark in 1000ml methanol extraction and evaporation [26] . We used 20x15cm eight Silica gel plates for purification using 100ml solvent (methanol:water:acetic acid; 50:40:10) in glass jar with cover lid. It was found that CU1 chemical ran fast near solvent front and get clustered with lines with slow moving due to association of chemicals. From stock dry mass, we dissolved 1g solid in 10ml ethanol, clarified by 10000rpm for 5min and loaded onto silica plate (1cm wide). The ascending chromatography was done for 65min, dried the plates at room temperature, scratched the gray areas and suspended in 20ml ethanol and dissolved chemical was ran another TLC. Scraped the dark chemical again, and ultimately dried at room temperature (60mg CU1 recovered per preparation). Similarly, CU2 and CU3 phyto-chemicals were purified under UV-shadow. About 95-99% pure CU1 was obtained by repeated TLC [8] . 5mg TLC-purified active sample dissolved in 0.5ml methanol, filtered through a membrane filter and 0.1ml sample was loaded onto a HPLC C-18 column equilibrated with methanol 0.5ml fractions were collected and major active peak (retention time-3min) was collected and vacuum dried [29] . Crude concentrated ethanol extract or TLC-purified chemicals were used for biochemical assays. TLC-purified CU1 chemical dissolved in water before assays and if ethanol extract used then added water during assay to lower ethanol concentration. Proton-NMR spectrometry was performed in CDCl 3 , D 2 O and CD 3 OD (4mg/ml CU1) for 10min. Carbon-NMR was performed in D 2 O only (20mg/ml CU1) in 500MHz JNM-ECX500 Spectrometer. We routinely used E. coli-KT-1_mdr and P. aeruginosa_PB-2_mdr for assay. The bacteria were resistant to ampicillin, ciprofloxacin, sulfamethoxazole, linezolid, vancomycin and moderate resistant to chloramphenicol, cefotaxime and streptomycin but sensitive to tigecycline and meropenem [8] . We also used linezolid, meropenem and amikacin resistant bacteria isolated from Ganga River water and Bay of Bengal sea water.100µl over night culture of MDR-bacteria was spread onto 10cm LB+ 1.5% Agar plate and 6mm holes were done and 40µl ethanolic solution of phyto-chemical added. In blank we loaded 40µl ethanol which usually did not interfere assay but rarely few strains of MDR bacteria gave minor lysis zone which likely was recovered (re-growth) during extended assay period. We determined >15mm lysis zone was good anti-bacterial activity where 20-30mm lysis zone could be detected for standard 20 µl of chloramphenicol (34mg/ml) or streptomycin (50mg/ml) or meropenem (1mg/ml) [12] . The assay used to measure RNAP activity was performed as described by In vitro replication assay was done as in Rudra et al., 2015 [35] . Single-stranded DNA Anti-bacterial activity was previously reported for ethanol extract of Cassia fistula bark [8, 12] . CU1 and CU3 anti-bacterial activities of TLC-purified phyto-chemicals were comparable but CU2 is less active. Five time concentrated extract or dried solubilised extract runs fastest moving chemical and CU2 is slower than CU1 and CU3 is slower than CU2 and much slower than CU1. We termed heterogeneous phytochemicals to explain the different derivatives of an extract or combination of 2-3 phyto-extracts from different plants and such extracts are good anti-bacterial drug and non-toxic [8] . Due to the multi-component nature of chemical structures, such heterogeneous phyto-antibiotics hard to become drug-resistant generating of mdr genes as well as activation drug-efflux genes. We purified the major phyto-chemicals CU1 and CU3 from 10-12 ml soluble ethanol extract using preparative TLC (20x15cm 8 plates and four solvent chambers) and 12 times such preparations were done and further TLC purification were repeated to make pure drug. Usually, we recovered ~300mg CU1/TLC purification scheme ( figure-2A) . We performed such purification scheme 3 times (in five years span) to perform all experiments (~1.2g CU1). Chemical analysis also showed it had saponin character as well as triterpenes ( figure-4) indicating a fused ring with polyphenolic substituent (figure-6). This interpretation was considered as phenolic compound and bromo-benzene both have primary peak at 210nm and secondary peaks at 270nm and 261nm respectively. So high peak at 210nm with secondary peak 275nm was justified for polyphenolic compound with multiple bromine where as for turpentine moiety further peak was shifted below 200nm was observed. FT-IR suggested broad band at 3650-2980cm -1 for -OH (stretching, ~3500cm -1 ) and C-H (stretching, ~3000cm -1 ) where as two strong peaks at 1552cm -1 for aromatic C=C (stretching) and 1408cm -1 for phenol (-OH bending). Minor peaks at 2360cm -1 with 2340cm -1 shoulder represented terpenetine double bond. Similarly, medium peaks at 1246cm -1 , 1159cm-1, 1105cm -1 , ~837cm -1 and 651cm -1 were detected (figure-7). The absorptions peaks at 1246cm -1, 1159cm -1 and 1105cm -1 may be for secondary alcohol (-OH bending), at 837cm -1 likely aromatic hydrogen and at 651cm -1 with 619cm -1 shoulder likely represented for different C-Br. However, we did not prepare any derivative yet to confirm structure. Proton-NMR confirmed polymeric phenol at . This difference may reflect differential solubilisation and polar effects as triterpene moity is poor soluble water that polyphenol moity. Carbon-NMR identified a strong peak at δ =23.7ppm for many C-Br and at δ =165 ppm for a polybenzoid compound whereas weak peaks for -CH2-and = C-carbons of triterpene were detected at δ = 54 and 65ppm (figure-9). More analyses were necessary for complete chemical structure prediction (in process). A multiple-round non-specific transcription assay was performed using calf-thymus DNA as template, 2µci 3 H-UTP as tracer and E. coli RNA polymerase. We found RNA polymerase activity was completely inhibited (complete-1325cpm, +Rif-63cpm, +CU1-75cpm, -Template DNA-52cpm) only with CU1 and NU2 phyto-chemicals but not with CU3, NU3, VU2, VU3, DU2, LU2, LU3 etc. The inhibitory activity of CU1 was comparable to drug refampicin and characterized further with priority (figure-10). To test the effect of CU1 on transcription by RNAP of Mycobacterium tuberculosis a fluorescence based in vitro transcription assay was performed. Here, the RNA product To further test the transcriptional repression activity of CU1, radioactivity based in vitro transcription assay was performed using The effectiveness of CU1 as a transcriptional inhibitor led to the investigation of its effect on bacterial DNA polymerase activity. For this study pUC19-sinP3 single-stranded DNA template was annealed with Cy5 labelled complementary primer. Then, the primer was allowed to be extended by Klenow fragment (E. coli DNA polymerase; NEB) using the annealed single-stranded DNA as template, in presence of increasing concentrations of CU1. The products were then resolved in a 12% urea-PAGE for visualization. The results show no significant change in DNA replication products formed in the presence of increasing concentrations of CU1 (Figure-15 ). This shows that CU1 does not affect bacterial DNA polymerase activity. This also suggested that CU1 did not bind to DNA alone. were potential source of anti-bacterial phytochemicals [8, 12, 25] . [36, 37] . Interestingly, Mycobacterium tuberculosis plasmids were rare and TB-specific drugs were different supporting authentic RNA polymerase inhibition by CU1 phyto-chemical led to a new drug discovery against TB [38] . Similarly, nature of Neiserria gonorrhoeae plasmids were different and many conventional drugs were reported non-functional indicating we needed more work on different in vivo assays in presence of CU1. CU2 or CU3 was not a inhibitor of RNA polymerase and at this point we did not predicts its molecular target. We coined the name "MDR-CURE" which was a mixture of five medicinal plants extracts with traditional anti-oxidant and anti-inflamitory principals from 50% ethanolic solution of Neem bark and Haldi ryzome [8] . When we injected MDR bacteria into rats, ampicillin or cefotaxime failed to clear infection but MDR-Cure cleared the 80-90% bacterial load in blood within two days [8] . Our method of CU1 isolation is cheap and any one can make 95% pure Multiple phyto-chemicals may also help to overcome the action of Tet, Acr, Mac and Mex types drug efflux proteins which also were detected in Kolkata MDR bacteria [8, 26] . Twenty types of Beta-lactamases were isolated in large MDR conjugative plasmids which contained 10-15 mdr genes, few drug efflux genes and mutated sul1/2/3, PBPs and gyrAB proteins. Chloramphenicol acetyltransferase and related enzymes (AacC1 and AacA1) were mutated to twenty types drug acetyltransferases inactivating many aminoglycosides (kanamycin) and fluoroquinolones (ciprofloxacin). Similarly, early detected streptomycin-phosphotransferase (StrA and StrB) were mutated to fifteen types APH phosphotransferases inactivating kanamycin, amikacin and gentamycin [36] [37] [38] [39] . Further, specific drug-inactivating mechanism also creating problem of TB therapy and Gonorrhoea control where as Cholera, Pneumonia and Typhoid were mostly drug resistant and 4-8 antibiotics were needed to clear infections [40] . Repeated drugs use may damage liver and kidney and may be reason for other metabolic diseases like diabetes and hypertension. So, herbal therapy is must and research must be augmented in that area. However, India has started plantation in large areas (Herbal Garden). Phage therapy may also be welcome but phage resistant factor is a big obstacle. We found Kolkata drain has some bacteriophages but hard to get phage particles in large number due to resistant factor during large scale re-infection assay (data not shown). Genetic engineering applications are used to make recombinant phages to overcome resistant factor but most data are hidden whereas virus mutagenesis is not a safe method. Genetic drugs (antisense, ribozyme) and gene therapy technologies will be costly and poor peoples of Asia, Africa and Latin America and poor peoples have limited access to such costly therapy (41) . Hundred thousand peoples were dragged into nasty poverty line every year due to high cost of antibiotics, anti-cancer and psychoactive drugs. In that scenario, MDR-Cure must be given priority by WHO and Leaders of G-20 Nations [42] . Repeated oral antibiotics uses have been reported worldwide which drives more mdr gene creation and drug void. Excessive synthetic drugs also damage the liver and kidney increasing metabolic diseases like high pressure, diabetes, hypertension and cancer. Thus, the need of MDR-Cure herbal drug against MDR pathogenesis is necessary and timing. We preliminary have characterized Cassia fistula (golden shower) CU1 phyto-chemical as complex structure of turpentine linked to bromopolyphenol but complete structure yet to determine. We suspected that 2-3 bromine might be also attached to triterpine moiety. How bromopolyphenol moiety was linked to triterpine was not sure at this point! As we also suspected a "S" atom (-SO 3 H group) in CU1 molecule which complicated our structure prediction. We are in process of characterizing other phyto-chemicals from Suregada multiflora, Jatropha gossipiifolia and Shorea robusta etc (figure-16). Such bark is available in large amount from a medium sized tree which can grow in unfertile land and no water treatment was found necessary during summer. It was reported that many pure phytochemicals are more toxic to animal cells that crude extract. In truth herbal drugs means crude drugs and licence for human use could be obtained easily. However, taxol, artiminisin, quinine types phyto-drugs have used as 95% pure similar to antibiotics (11). Thus, our approached to purify and characterize the CU1 phyto-chemical in detail to formulate as MDR-Cure drug is justified. Pure TLC purified CU1 was very active and such drug could be obtained at low cost. We have selected six plants and spices to make MDR-Cure and such drugs in combination will be effective against pan drug resistant bacteria. Definitely more work necessary to pinpoint final structure of CU1 and also clinical study necessary before its use as prescription drug. Our MDR-cure lotion cures many human MDR nail infection (unpublished data). Abundant CU1 antibiotic is novel, water soluble and will also help to understand the molecular mechanism of RNA synthesis in bacteria as there are very few drugs available today for RNA polymerase inhibition study and drug design against MDR bacteria. The Comprehensive Antibiotic Resistance Database Multidrug-Resistant bacteria with activated and diversified MDR Genes in Kolkata water: Ganga Action Plan and Heterogeneous Phyto-Antibiotics tackling superbug spread in India Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum beta-lactamases and carbapenemases) Multi-drug resistant genes in bacteria and 21 st Century problems associated with antibiotic therapy A functional scheme for β -lactamases and its correlation with molecular structure Complexity, heterogeneity, 3-D structures and transcriptional activation of multi-drug resistant clinically relevant bacterial beta-lactamases In silico analysis of hotspot mutations in the bacterial NDM-1 and KPC-1 carbapenemases that cause severe MDR phenotypes Multi-drug resistant bacteria from Kolkata Ganga River with heterogeneous MDR genes have four hallmarks of cancer cells but could be controlled by organic phyto-extracts MDR genes are created and transmitted in plasmids and chromosomes to keep normal intestinal microbiota alive against high dose antibiotics-a hypothesis Mechanisms of AMR: Bacteria won the battle against antibiotics Heterogeneous phyto-antibiotics and other future therapeutics against multi-drug resistant bacteria High mode contamination of multi-drug resistant bacteria in Kolkata: mechanism of gene activation and remedy by heterogeneous phyto-antibiotics Traditional medicinal uses, phytochemical profile and pharmacological activities of Cassia fistula Linn In vitro antibacterial and antifungal activities of Cassia fistula Linn. fruit pulp extracts Phytochemical and pharmacological review on Cassia fistula Linn. The golden shower Antibacterial Activity of Fistulin: A Protease Inhibitor Purified from the Leaves of Cassia fistula ISRN Pharm Constituents of Cassia fistula roots Phytochemical constituents of cassia fistula Gibberellic acid in the floral parts of cassia fistula Chemical investigation on Cassia occidentalis Linn. : Isolation and structure of cassiolin, a new xanthone A review on Cassia fistula Altered chemical properties in three mutants of E. coli RNA polymerase sigma subunit Animal DNA-dependent RNA polymerases. Molecular structures and immunological properties of calf-thymus enzyme AI and of calfthymus and rat-liver enzymes B Purification of rat liver and mouse ascites DNA-dependent RNA polymerase I Fluorescence resonance energy transfer (FRET) in analysis of transcription-complex structure and function Ganga action plan, heterogeneous phyt-antibiotics and phage therapy are the best hope for India tackling superbug spread and control General Introduction Molecular Cloning: A Laboratory Manual. 2 nd ed Metabolite profiling and isolation of biologically active compounds from Scadoxus puniceus, a highly traded South African medicinal plant Optimization of recombinant Mycobacterium tuberculosis RNA polymerase expression and purification Mode of Action of a designed antimicrobial peptide: high potency against Cryptococcus neoformans Novel mechanism of gene regulation: The protein Rv1222 of Mycobacterium tuberculosis inhibits transcription by anchoring the RNA polymerase onto DNA Complexity, heterogeneity and mutational analysis of antibiotic inactivating acetyl transferases in MDR conjugative plasmids conferring multi-resistance Complexity of OXA Beta-Lactamases involved in Multi-Resistance Current status and unusual mechanism of multi-resistance in Mycobacterium tuberculosis Poor correlation of diversified MDR genes in Gonococci plasmids: Does alteration in chromosomal DEGs, PBP2 and Target Mutations sufficient to widespread multi-resistance in Neisseria gonorrhoeae? High Prevalence of metal resistant genes in Salmonella enterica MDR Plasmids correlates severe toxicities of water with higher Typhoid AMR Synthetic Retrotransposon vectors for Gene Therapy Nucleic-Acids Based Nanocarriers, in "Nanocarriers for Drug Delivery We are sad to state the sudden demise of Dr J. B No human patient was used. Rat and Molly fish experiments with CU1 were discussed with Institutional Ethics Committee. All authors declared no conflict of interest. inner bark and C. zeynalicum flower bud (derchini) were extracted in ethanol, concentrated five times before Kirby-Bauer agar-hole anti-bacterial assay. We are sure that any multi-drug resistant infection will be cured by such extracts in combination where as purified phytochemicals using preparative TLC are equally good.